Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Eculizumab> ?p ?o }
- Eculizumab abstract "Eculizumab (INN and USAN; trade name Soliris) is a humanized monoclonal antibody that is a terminal complement inhibitor. In people with paroxysmal nocturnal hemoglobinuria (PNH) it improves quality of life but does not appear to affect the risk of death. Its safety is unclear as of 2014. It is the first approved therapy for paroxysmal nocturnal hemoglobinuria. Eculizumab is also the first agent approved treatment of atypical hemolytic uremic syndrome (aHUS) with likely benefit based on two small trials.Eculizumab was developed and is manufactured and marketed by Connecticut-based Alexion Pharmaceuticals. It was approved by the United States Food and Drug Administration (FDA) on March 16, 2007 for the treatment of PNH, and on September 23, 2011 for the treatment of aHUS. It was approved by the European Medicines Agency for the treatment of PNH on June 20, 2007, and on November 24, 2011 for the treatment of aHUS. Eculizumab is currently being investigated as a potential treatment for other rare disorders. Eculizumab has exclusivity rights until 2017 which protects it from competition from biosimilar applications until 2017.Soliris is considered to be the most expensive drug in the world. It costs £340,200 (approximately €430,000) per year for ongoing treatment in the UK and $500,000 a year in Canada. and US$409,500 a year in the United States (2010). In the case of the rarest diseases that afflict fewer than 10,000 people, biotech companies who own the only approved drugs to treat those diseases "can charge pretty much whatever they want." "Before testing Soliris for PNH, Alexion tested the drug for rheumatoid arthritis, which afflicts 1 million Americans. The trials failed. But if it had worked for arthritis, Alexion would likely have had to charge a much lower price for this use, as it would have to compete against drugs that cost a mere $20,000." Alexion started selling Soliris in 2008 making $295 million in 2007 with its stock price rising to 130% in 2010.".
- Eculizumab atcPrefix "L04".
- Eculizumab atcSuffix "AA25".
- Eculizumab casNumber "219685-50-4".
- Eculizumab drugbank "DB01257".
- Eculizumab fdaUniiCode "A3ULP0F556".
- Eculizumab wikiPageExternalLink soliris.net.
- Eculizumab wikiPageExternalLink globulerougeexplose.html.
- Eculizumab wikiPageID "7086253".
- Eculizumab wikiPageLength "45616".
- Eculizumab wikiPageOutDegree "85".
- Eculizumab wikiPageRevisionID "683306802".
- Eculizumab wikiPageWikiLink Acute_myelogenous_leukemia.
- Eculizumab wikiPageWikiLink Acute_myeloid_leukemia.
- Eculizumab wikiPageWikiLink Adverse_effect.
- Eculizumab wikiPageWikiLink Adverse_events.
- Eculizumab wikiPageWikiLink Alexion_Pharmaceuticals.
- Eculizumab wikiPageWikiLink Alternative_complement_pathway.
- Eculizumab wikiPageWikiLink Anemia.
- Eculizumab wikiPageWikiLink Antibody.
- Eculizumab wikiPageWikiLink Aplastic_anemia.
- Eculizumab wikiPageWikiLink Atomic_mass_unit.
- Eculizumab wikiPageWikiLink Atypical_hemolytic_uremic_syndrome.
- Eculizumab wikiPageWikiLink Basement_membrane.
- Eculizumab wikiPageWikiLink Blood_plasma.
- Eculizumab wikiPageWikiLink C3_glomerulonephritis.
- Eculizumab wikiPageWikiLink C5-convertase.
- Eculizumab wikiPageWikiLink C5_convertase.
- Eculizumab wikiPageWikiLink Canada.
- Eculizumab wikiPageWikiLink Canadian_Patent_Act.
- Eculizumab wikiPageWikiLink Category:Immunosuppressants.
- Eculizumab wikiPageWikiLink Category:Orphan_drugs.
- Eculizumab wikiPageWikiLink Chronic_kidney_disease.
- Eculizumab wikiPageWikiLink Common_cold.
- Eculizumab wikiPageWikiLink Complement_component_5.
- Eculizumab wikiPageWikiLink Complement_component_5a.
- Eculizumab wikiPageWikiLink Complement_factor_H.
- Eculizumab wikiPageWikiLink Complement_protein.
- Eculizumab wikiPageWikiLink Complement_system.
- Eculizumab wikiPageWikiLink Creatinine.
- Eculizumab wikiPageWikiLink Diarrhea.
- Eculizumab wikiPageWikiLink End-stage_renal_disease.
- Eculizumab wikiPageWikiLink Enzyme.
- Eculizumab wikiPageWikiLink Enzymes.
- Eculizumab wikiPageWikiLink Escherichia_coli_O104:H4.
- Eculizumab wikiPageWikiLink Escherichia_coli_O157:H7.
- Eculizumab wikiPageWikiLink European_Medicines_Agency.
- Eculizumab wikiPageWikiLink Factor_H.
- Eculizumab wikiPageWikiLink Fatigue_(medical).
- Eculizumab wikiPageWikiLink Food_and_Drug_Administration.
- Eculizumab wikiPageWikiLink Forbes.
- Eculizumab wikiPageWikiLink Glomerulonephritis.
- Eculizumab wikiPageWikiLink Glomerulus.
- Eculizumab wikiPageWikiLink Government_of_Ontario.
- Eculizumab wikiPageWikiLink Headache.
- Eculizumab wikiPageWikiLink Hematuria.
- Eculizumab wikiPageWikiLink Hemolytic-uremic_syndrome.
- Eculizumab wikiPageWikiLink Humanized_antibody.
- Eculizumab wikiPageWikiLink Humanized_monoclonal_antibody.
- Eculizumab wikiPageWikiLink Hypertension.
- Eculizumab wikiPageWikiLink Hypoalbuminemia.
- Eculizumab wikiPageWikiLink Immune_system.
- Eculizumab wikiPageWikiLink Immunoglobulin.
- Eculizumab wikiPageWikiLink International_Nonproprietary_Name.
- Eculizumab wikiPageWikiLink Intravenous_therapy.
- Eculizumab wikiPageWikiLink Lactate_dehydrogenase.
- Eculizumab wikiPageWikiLink Lysosomal.
- Eculizumab wikiPageWikiLink Lysosome.
- Eculizumab wikiPageWikiLink Membranoproliferative_glomerulonephritis.
- Eculizumab wikiPageWikiLink Mesangiocapillary_glomerulonephritis.
- Eculizumab wikiPageWikiLink Metabolism.
- Eculizumab wikiPageWikiLink Molecular_mass.
- Eculizumab wikiPageWikiLink Molecular_weight.
- Eculizumab wikiPageWikiLink Monoclonal_antibodies.
- Eculizumab wikiPageWikiLink Monoclonal_antibody.
- Eculizumab wikiPageWikiLink Myelodysplastic_syndrome.
- Eculizumab wikiPageWikiLink Nasopharyngitis.
- Eculizumab wikiPageWikiLink Nausea.
- Eculizumab wikiPageWikiLink Neisseria_meningitidis.
- Eculizumab wikiPageWikiLink Nephritis.
- Eculizumab wikiPageWikiLink New_Zealand.
- Eculizumab wikiPageWikiLink Optic_neuritis.
- Eculizumab wikiPageWikiLink Orphan_drug.
- Eculizumab wikiPageWikiLink Paroxysmal_nocturnal_hemoglobinuria.
- Eculizumab wikiPageWikiLink Patent_Act_(Canada).
- Eculizumab wikiPageWikiLink Patented_Medicine_Prices_Review_Board.
- Eculizumab wikiPageWikiLink Peptide.
- Eculizumab wikiPageWikiLink Peptides.
- Eculizumab wikiPageWikiLink Pharmac.
- Eculizumab wikiPageWikiLink Pharmaceutical_Management_Agency.
- Eculizumab wikiPageWikiLink Renal_function.
- Eculizumab wikiPageWikiLink Rheumatoid_arthritis.
- Eculizumab wikiPageWikiLink Serious_adverse_event.
- Eculizumab wikiPageWikiLink Serum_creatinine.
- Eculizumab wikiPageWikiLink Shiga_toxin.
- Eculizumab wikiPageWikiLink Tax_incentive.
- Eculizumab wikiPageWikiLink Thrombocytopenia.
- Eculizumab wikiPageWikiLink Thrombotic_microangiopathy.
- Eculizumab wikiPageWikiLink Trans-Pacific_Partnership.
- Eculizumab wikiPageWikiLink Transverse_myelitis.